Tekla Capital Management LLC Catalent, Inc. Transaction History

Tekla Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$45.44 - $74.26 $3.48 Million - $5.68 Million	-76,541 Reduced 60.77%	49,406 $3.25 Million
Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $5.21 Million - $10.2 Million	125,947 New	125,947 $5.67 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $17.2 Million - $20 Million	-143,913 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $6.97 Million - $9.09 Million	63,888 Added 79.84%	143,913 $19.2 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $8.12 Million - $10 Million	80,025 New	80,025 $8.43 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.